nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—ALB—Erlotinib—pancreatic cancer	0.108	0.178	CbGbCtD
Cephalexin—ALB—Irinotecan—pancreatic cancer	0.0975	0.161	CbGbCtD
Cephalexin—ALB—Fluorouracil—pancreatic cancer	0.0935	0.154	CbGbCtD
Cephalexin—CYP2D6—Tamoxifen—pancreatic cancer	0.0626	0.103	CbGbCtD
Cephalexin—CYP2D6—Erlotinib—pancreatic cancer	0.0532	0.0877	CbGbCtD
Cephalexin—CYP3A4—Tamoxifen—pancreatic cancer	0.0398	0.0656	CbGbCtD
Cephalexin—CYP3A4—Erlotinib—pancreatic cancer	0.0338	0.0558	CbGbCtD
Cephalexin—CYP3A4—Irinotecan—pancreatic cancer	0.0305	0.0504	CbGbCtD
Cephalexin—CYP2D6—Doxorubicin—pancreatic cancer	0.0262	0.0433	CbGbCtD
Cephalexin—CYP3A4—Docetaxel—pancreatic cancer	0.0224	0.0369	CbGbCtD
Cephalexin—CYP3A4—Sunitinib—pancreatic cancer	0.0223	0.0368	CbGbCtD
Cephalexin—CYP3A4—Doxorubicin—pancreatic cancer	0.0167	0.0275	CbGbCtD
Cephalexin—Body temperature increased—Erlotinib—pancreatic cancer	0.000843	0.00214	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000841	0.00214	CcSEcCtD
Cephalexin—Leukopenia—Irinotecan—pancreatic cancer	0.000834	0.00212	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Epirubicin—pancreatic cancer	0.00083	0.00211	CcSEcCtD
Cephalexin—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.000826	0.0021	CcSEcCtD
Cephalexin—Infestation NOS—Docetaxel—pancreatic cancer	0.000825	0.0021	CcSEcCtD
Cephalexin—Infestation—Docetaxel—pancreatic cancer	0.000825	0.0021	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000818	0.00208	CcSEcCtD
Cephalexin—Dyspepsia—Sunitinib—pancreatic cancer	0.000813	0.00207	CcSEcCtD
Cephalexin—Leukopenia—Gemcitabine—pancreatic cancer	0.000813	0.00207	CcSEcCtD
Cephalexin—Leukopenia—Fluorouracil—pancreatic cancer	0.000799	0.00203	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000797	0.00203	CcSEcCtD
Cephalexin—Fatigue—Sunitinib—pancreatic cancer	0.000796	0.00202	CcSEcCtD
Cephalexin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000795	0.00202	CcSEcCtD
Cephalexin—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.00078	0.00198	CcSEcCtD
Cephalexin—Asthenia—Tamoxifen—pancreatic cancer	0.000774	0.00197	CcSEcCtD
Cephalexin—Convulsion—Fluorouracil—pancreatic cancer	0.000774	0.00197	CcSEcCtD
Cephalexin—Arthralgia—Gemcitabine—pancreatic cancer	0.000773	0.00196	CcSEcCtD
Cephalexin—Agranulocytosis—Docetaxel—pancreatic cancer	0.00077	0.00196	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Doxorubicin—pancreatic cancer	0.000768	0.00195	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000768	0.00195	CcSEcCtD
Cephalexin—Confusional state—Irinotecan—pancreatic cancer	0.000767	0.00195	CcSEcCtD
Cephalexin—Asthenia—Erlotinib—pancreatic cancer	0.000765	0.00194	CcSEcCtD
Cephalexin—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000764	0.00194	CcSEcCtD
Cephalexin—Pruritus—Tamoxifen—pancreatic cancer	0.000763	0.00194	CcSEcCtD
Cephalexin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000761	0.00193	CcSEcCtD
Cephalexin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000755	0.00192	CcSEcCtD
Cephalexin—Pruritus—Erlotinib—pancreatic cancer	0.000755	0.00192	CcSEcCtD
Cephalexin—Nervous system disorder—Irinotecan—pancreatic cancer	0.000746	0.0019	CcSEcCtD
Cephalexin—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000745	0.00189	CcSEcCtD
Cephalexin—Haemoglobin—Docetaxel—pancreatic cancer	0.000744	0.00189	CcSEcCtD
Cephalexin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000741	0.00188	CcSEcCtD
Cephalexin—Hepatitis—Docetaxel—pancreatic cancer	0.00074	0.00188	CcSEcCtD
Cephalexin—Haemorrhage—Docetaxel—pancreatic cancer	0.00074	0.00188	CcSEcCtD
Cephalexin—Diarrhoea—Tamoxifen—pancreatic cancer	0.000738	0.00187	CcSEcCtD
Cephalexin—Confusional state—Fluorouracil—pancreatic cancer	0.000735	0.00187	CcSEcCtD
Cephalexin—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000731	0.00186	CcSEcCtD
Cephalexin—Abdominal pain—Sunitinib—pancreatic cancer	0.00073	0.00186	CcSEcCtD
Cephalexin—Body temperature increased—Sunitinib—pancreatic cancer	0.00073	0.00186	CcSEcCtD
Cephalexin—Diarrhoea—Erlotinib—pancreatic cancer	0.00073	0.00185	CcSEcCtD
Cephalexin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000729	0.00185	CcSEcCtD
Cephalexin—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000727	0.00185	CcSEcCtD
Cephalexin—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000727	0.00185	CcSEcCtD
Cephalexin—Urethral disorder—Docetaxel—pancreatic cancer	0.000726	0.00184	CcSEcCtD
Cephalexin—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000726	0.00184	CcSEcCtD
Cephalexin—Osteoarthritis—Epirubicin—pancreatic cancer	0.000722	0.00183	CcSEcCtD
Cephalexin—Skin disorder—Gemcitabine—pancreatic cancer	0.00072	0.00183	CcSEcCtD
Cephalexin—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000715	0.00182	CcSEcCtD
Cephalexin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000713	0.00181	CcSEcCtD
Cephalexin—Dizziness—Tamoxifen—pancreatic cancer	0.000713	0.00181	CcSEcCtD
Cephalexin—Dizziness—Erlotinib—pancreatic cancer	0.000706	0.00179	CcSEcCtD
Cephalexin—Erythema multiforme—Docetaxel—pancreatic cancer	0.0007	0.00178	CcSEcCtD
Cephalexin—Vomiting—Tamoxifen—pancreatic cancer	0.000686	0.00174	CcSEcCtD
Cephalexin—Hypersensitivity—Sunitinib—pancreatic cancer	0.00068	0.00173	CcSEcCtD
Cephalexin—Rash—Tamoxifen—pancreatic cancer	0.00068	0.00173	CcSEcCtD
Cephalexin—Dermatitis—Tamoxifen—pancreatic cancer	0.000679	0.00173	CcSEcCtD
Cephalexin—Vomiting—Erlotinib—pancreatic cancer	0.000678	0.00172	CcSEcCtD
Cephalexin—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000676	0.00172	CcSEcCtD
Cephalexin—Headache—Tamoxifen—pancreatic cancer	0.000676	0.00172	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000675	0.00172	CcSEcCtD
Cephalexin—Rash—Erlotinib—pancreatic cancer	0.000673	0.00171	CcSEcCtD
Cephalexin—Dermatitis—Erlotinib—pancreatic cancer	0.000672	0.00171	CcSEcCtD
Cephalexin—Dyspepsia—Irinotecan—pancreatic cancer	0.00067	0.0017	CcSEcCtD
Cephalexin—Immune system disorder—Docetaxel—pancreatic cancer	0.000669	0.0017	CcSEcCtD
Cephalexin—Headache—Erlotinib—pancreatic cancer	0.000668	0.0017	CcSEcCtD
Cephalexin—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000668	0.0017	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000664	0.00169	CcSEcCtD
Cephalexin—Asthenia—Sunitinib—pancreatic cancer	0.000663	0.00168	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000657	0.00167	CcSEcCtD
Cephalexin—Fatigue—Irinotecan—pancreatic cancer	0.000656	0.00167	CcSEcCtD
Cephalexin—Pruritus—Sunitinib—pancreatic cancer	0.000653	0.00166	CcSEcCtD
Cephalexin—Breast disorder—Epirubicin—pancreatic cancer	0.000652	0.00166	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00065	0.00165	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.00065	0.00165	CcSEcCtD
Cephalexin—Mental disorder—Docetaxel—pancreatic cancer	0.000649	0.00165	CcSEcCtD
Cephalexin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000641	0.00163	CcSEcCtD
Cephalexin—Nausea—Tamoxifen—pancreatic cancer	0.000641	0.00163	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00064	0.00163	CcSEcCtD
Cephalexin—Fatigue—Gemcitabine—pancreatic cancer	0.000639	0.00162	CcSEcCtD
Cephalexin—Gastritis—Epirubicin—pancreatic cancer	0.000639	0.00162	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000637	0.00162	CcSEcCtD
Cephalexin—Nausea—Erlotinib—pancreatic cancer	0.000634	0.00161	CcSEcCtD
Cephalexin—Diarrhoea—Sunitinib—pancreatic cancer	0.000632	0.00161	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000629	0.0016	CcSEcCtD
Cephalexin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000627	0.00159	CcSEcCtD
Cephalexin—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000626	0.00159	CcSEcCtD
Cephalexin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000622	0.00158	CcSEcCtD
Cephalexin—Eosinophilia—Epirubicin—pancreatic cancer	0.000618	0.00157	CcSEcCtD
Cephalexin—Dizziness—Sunitinib—pancreatic cancer	0.000611	0.00155	CcSEcCtD
Cephalexin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000611	0.00155	CcSEcCtD
Cephalexin—Breast disorder—Doxorubicin—pancreatic cancer	0.000603	0.00153	CcSEcCtD
Cephalexin—Abdominal pain—Irinotecan—pancreatic cancer	0.000601	0.00153	CcSEcCtD
Cephalexin—Body temperature increased—Irinotecan—pancreatic cancer	0.000601	0.00153	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000601	0.00153	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000601	0.00153	CcSEcCtD
Cephalexin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.0006	0.00153	CcSEcCtD
Cephalexin—Pancytopenia—Epirubicin—pancreatic cancer	0.000592	0.00151	CcSEcCtD
Cephalexin—Gastritis—Doxorubicin—pancreatic cancer	0.000591	0.0015	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000589	0.0015	CcSEcCtD
Cephalexin—Vomiting—Sunitinib—pancreatic cancer	0.000587	0.00149	CcSEcCtD
Cephalexin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000586	0.00149	CcSEcCtD
Cephalexin—Neutropenia—Epirubicin—pancreatic cancer	0.000583	0.00148	CcSEcCtD
Cephalexin—Rash—Sunitinib—pancreatic cancer	0.000582	0.00148	CcSEcCtD
Cephalexin—Dermatitis—Sunitinib—pancreatic cancer	0.000582	0.00148	CcSEcCtD
Cephalexin—Urticaria—Fluorouracil—pancreatic cancer	0.000579	0.00147	CcSEcCtD
Cephalexin—Headache—Sunitinib—pancreatic cancer	0.000579	0.00147	CcSEcCtD
Cephalexin—Leukopenia—Docetaxel—pancreatic cancer	0.000577	0.00147	CcSEcCtD
Cephalexin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000576	0.00146	CcSEcCtD
Cephalexin—Eosinophilia—Doxorubicin—pancreatic cancer	0.000571	0.00145	CcSEcCtD
Cephalexin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000561	0.00142	CcSEcCtD
Cephalexin—Convulsion—Docetaxel—pancreatic cancer	0.000558	0.00142	CcSEcCtD
Cephalexin—Infestation NOS—Epirubicin—pancreatic cancer	0.000556	0.00141	CcSEcCtD
Cephalexin—Infestation—Epirubicin—pancreatic cancer	0.000556	0.00141	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000551	0.0014	CcSEcCtD
Cephalexin—Arthralgia—Docetaxel—pancreatic cancer	0.000549	0.00139	CcSEcCtD
Cephalexin—Nausea—Sunitinib—pancreatic cancer	0.000549	0.00139	CcSEcCtD
Cephalexin—Pancytopenia—Doxorubicin—pancreatic cancer	0.000548	0.00139	CcSEcCtD
Cephalexin—Asthenia—Irinotecan—pancreatic cancer	0.000546	0.00139	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000545	0.00138	CcSEcCtD
Cephalexin—Neutropenia—Doxorubicin—pancreatic cancer	0.00054	0.00137	CcSEcCtD
Cephalexin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000537	0.00136	CcSEcCtD
Cephalexin—Asthenia—Gemcitabine—pancreatic cancer	0.000532	0.00135	CcSEcCtD
Cephalexin—Confusional state—Docetaxel—pancreatic cancer	0.00053	0.00135	CcSEcCtD
Cephalexin—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000526	0.00134	CcSEcCtD
Cephalexin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000526	0.00134	CcSEcCtD
Cephalexin—Pruritus—Gemcitabine—pancreatic cancer	0.000524	0.00133	CcSEcCtD
Cephalexin—Diarrhoea—Irinotecan—pancreatic cancer	0.000521	0.00132	CcSEcCtD
Cephalexin—Agranulocytosis—Epirubicin—pancreatic cancer	0.000519	0.00132	CcSEcCtD
Cephalexin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000516	0.00131	CcSEcCtD
Cephalexin—Pruritus—Fluorouracil—pancreatic cancer	0.000516	0.00131	CcSEcCtD
Cephalexin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000515	0.00131	CcSEcCtD
Cephalexin—Infestation—Doxorubicin—pancreatic cancer	0.000515	0.00131	CcSEcCtD
Cephalexin—Infestation NOS—Doxorubicin—pancreatic cancer	0.000515	0.00131	CcSEcCtD
Cephalexin—Skin disorder—Docetaxel—pancreatic cancer	0.000511	0.0013	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00051	0.0013	CcSEcCtD
Cephalexin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000507	0.00129	CcSEcCtD
Cephalexin—Dizziness—Irinotecan—pancreatic cancer	0.000503	0.00128	CcSEcCtD
Cephalexin—Haemoglobin—Epirubicin—pancreatic cancer	0.000502	0.00127	CcSEcCtD
Cephalexin—Haemorrhage—Epirubicin—pancreatic cancer	0.000499	0.00127	CcSEcCtD
Cephalexin—Hepatitis—Epirubicin—pancreatic cancer	0.000499	0.00127	CcSEcCtD
Cephalexin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000499	0.00127	CcSEcCtD
Cephalexin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000493	0.00125	CcSEcCtD
Cephalexin—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000491	0.00125	CcSEcCtD
Cephalexin—Urethral disorder—Epirubicin—pancreatic cancer	0.000489	0.00124	CcSEcCtD
Cephalexin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000487	0.00124	CcSEcCtD
Cephalexin—Vomiting—Irinotecan—pancreatic cancer	0.000484	0.00123	CcSEcCtD
Cephalexin—Dizziness—Fluorouracil—pancreatic cancer	0.000482	0.00122	CcSEcCtD
Cephalexin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00048	0.00122	CcSEcCtD
Cephalexin—Rash—Irinotecan—pancreatic cancer	0.00048	0.00122	CcSEcCtD
Cephalexin—Dermatitis—Irinotecan—pancreatic cancer	0.000479	0.00122	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000479	0.00122	CcSEcCtD
Cephalexin—Headache—Irinotecan—pancreatic cancer	0.000477	0.00121	CcSEcCtD
Cephalexin—Erythema multiforme—Epirubicin—pancreatic cancer	0.000472	0.0012	CcSEcCtD
Cephalexin—Vomiting—Gemcitabine—pancreatic cancer	0.000471	0.0012	CcSEcCtD
Cephalexin—Rash—Gemcitabine—pancreatic cancer	0.000467	0.00119	CcSEcCtD
Cephalexin—Dermatitis—Gemcitabine—pancreatic cancer	0.000467	0.00119	CcSEcCtD
Cephalexin—Haemoglobin—Doxorubicin—pancreatic cancer	0.000464	0.00118	CcSEcCtD
Cephalexin—Headache—Gemcitabine—pancreatic cancer	0.000464	0.00118	CcSEcCtD
Cephalexin—Vomiting—Fluorouracil—pancreatic cancer	0.000463	0.00118	CcSEcCtD
Cephalexin—Dyspepsia—Docetaxel—pancreatic cancer	0.000463	0.00118	CcSEcCtD
Cephalexin—Haemorrhage—Doxorubicin—pancreatic cancer	0.000462	0.00117	CcSEcCtD
Cephalexin—Hepatitis—Doxorubicin—pancreatic cancer	0.000462	0.00117	CcSEcCtD
Cephalexin—Rash—Fluorouracil—pancreatic cancer	0.000459	0.00117	CcSEcCtD
Cephalexin—Dermatitis—Fluorouracil—pancreatic cancer	0.000459	0.00117	CcSEcCtD
Cephalexin—Headache—Fluorouracil—pancreatic cancer	0.000456	0.00116	CcSEcCtD
Cephalexin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000456	0.00116	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000454	0.00115	CcSEcCtD
Cephalexin—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000454	0.00115	CcSEcCtD
Cephalexin—Fatigue—Docetaxel—pancreatic cancer	0.000453	0.00115	CcSEcCtD
Cephalexin—Urethral disorder—Doxorubicin—pancreatic cancer	0.000453	0.00115	CcSEcCtD
Cephalexin—Nausea—Irinotecan—pancreatic cancer	0.000452	0.00115	CcSEcCtD
Cephalexin—Immune system disorder—Epirubicin—pancreatic cancer	0.000451	0.00115	CcSEcCtD
Cephalexin—Nausea—Gemcitabine—pancreatic cancer	0.00044	0.00112	CcSEcCtD
Cephalexin—Mental disorder—Epirubicin—pancreatic cancer	0.000437	0.00111	CcSEcCtD
Cephalexin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000437	0.00111	CcSEcCtD
Cephalexin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000433	0.0011	CcSEcCtD
Cephalexin—Nausea—Fluorouracil—pancreatic cancer	0.000433	0.0011	CcSEcCtD
Cephalexin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00043	0.00109	CcSEcCtD
Cephalexin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000417	0.00106	CcSEcCtD
Cephalexin—Abdominal pain—Docetaxel—pancreatic cancer	0.000416	0.00106	CcSEcCtD
Cephalexin—Body temperature increased—Docetaxel—pancreatic cancer	0.000416	0.00106	CcSEcCtD
Cephalexin—Mental disorder—Doxorubicin—pancreatic cancer	0.000405	0.00103	CcSEcCtD
Cephalexin—Agitation—Epirubicin—pancreatic cancer	0.000399	0.00101	CcSEcCtD
Cephalexin—Leukopenia—Epirubicin—pancreatic cancer	0.000389	0.000988	CcSEcCtD
Cephalexin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000387	0.000984	CcSEcCtD
Cephalexin—Asthenia—Docetaxel—pancreatic cancer	0.000377	0.000959	CcSEcCtD
Cephalexin—Convulsion—Epirubicin—pancreatic cancer	0.000377	0.000957	CcSEcCtD
Cephalexin—Pruritus—Docetaxel—pancreatic cancer	0.000372	0.000945	CcSEcCtD
Cephalexin—Arthralgia—Epirubicin—pancreatic cancer	0.00037	0.00094	CcSEcCtD
Cephalexin—Agitation—Doxorubicin—pancreatic cancer	0.00037	0.000939	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000367	0.000934	CcSEcCtD
Cephalexin—Leukopenia—Doxorubicin—pancreatic cancer	0.00036	0.000915	CcSEcCtD
Cephalexin—Diarrhoea—Docetaxel—pancreatic cancer	0.00036	0.000914	CcSEcCtD
Cephalexin—Confusional state—Epirubicin—pancreatic cancer	0.000358	0.000909	CcSEcCtD
Cephalexin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000355	0.000901	CcSEcCtD
Cephalexin—Convulsion—Doxorubicin—pancreatic cancer	0.000348	0.000885	CcSEcCtD
Cephalexin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000348	0.000884	CcSEcCtD
Cephalexin—Dizziness—Docetaxel—pancreatic cancer	0.000348	0.000884	CcSEcCtD
Cephalexin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000347	0.000882	CcSEcCtD
Cephalexin—Skin disorder—Epirubicin—pancreatic cancer	0.000345	0.000875	CcSEcCtD
Cephalexin—Arthralgia—Doxorubicin—pancreatic cancer	0.000342	0.00087	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00034	0.000864	CcSEcCtD
Cephalexin—Vomiting—Docetaxel—pancreatic cancer	0.000334	0.00085	CcSEcCtD
Cephalexin—Rash—Docetaxel—pancreatic cancer	0.000332	0.000842	CcSEcCtD
Cephalexin—Dermatitis—Docetaxel—pancreatic cancer	0.000331	0.000842	CcSEcCtD
Cephalexin—Confusional state—Doxorubicin—pancreatic cancer	0.000331	0.000841	CcSEcCtD
Cephalexin—Headache—Docetaxel—pancreatic cancer	0.000329	0.000837	CcSEcCtD
Cephalexin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000328	0.000834	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000323	0.000821	CcSEcCtD
Cephalexin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000322	0.000818	CcSEcCtD
Cephalexin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000321	0.000816	CcSEcCtD
Cephalexin—Skin disorder—Doxorubicin—pancreatic cancer	0.000319	0.00081	CcSEcCtD
Cephalexin—Nausea—Docetaxel—pancreatic cancer	0.000312	0.000794	CcSEcCtD
Cephalexin—Dyspepsia—Epirubicin—pancreatic cancer	0.000312	0.000793	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000306	0.000778	CcSEcCtD
Cephalexin—Fatigue—Epirubicin—pancreatic cancer	0.000306	0.000777	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000299	0.00076	CcSEcCtD
Cephalexin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000292	0.000743	CcSEcCtD
Cephalexin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00029	0.000737	CcSEcCtD
Cephalexin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000289	0.000734	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000283	0.00072	CcSEcCtD
Cephalexin—Fatigue—Doxorubicin—pancreatic cancer	0.000283	0.000719	CcSEcCtD
Cephalexin—Urticaria—Epirubicin—pancreatic cancer	0.000282	0.000716	CcSEcCtD
Cephalexin—Body temperature increased—Epirubicin—pancreatic cancer	0.00028	0.000712	CcSEcCtD
Cephalexin—Abdominal pain—Epirubicin—pancreatic cancer	0.00028	0.000712	CcSEcCtD
Cephalexin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00027	0.000687	CcSEcCtD
Cephalexin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000268	0.000682	CcSEcCtD
Cephalexin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000261	0.000664	CcSEcCtD
Cephalexin—Urticaria—Doxorubicin—pancreatic cancer	0.000261	0.000662	CcSEcCtD
Cephalexin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000259	0.000659	CcSEcCtD
Cephalexin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000259	0.000659	CcSEcCtD
Cephalexin—Asthenia—Epirubicin—pancreatic cancer	0.000255	0.000647	CcSEcCtD
Cephalexin—Pruritus—Epirubicin—pancreatic cancer	0.000251	0.000638	CcSEcCtD
Cephalexin—Diarrhoea—Epirubicin—pancreatic cancer	0.000243	0.000617	CcSEcCtD
Cephalexin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000242	0.000614	CcSEcCtD
Cephalexin—Asthenia—Doxorubicin—pancreatic cancer	0.000235	0.000598	CcSEcCtD
Cephalexin—Dizziness—Epirubicin—pancreatic cancer	0.000235	0.000596	CcSEcCtD
Cephalexin—Pruritus—Doxorubicin—pancreatic cancer	0.000232	0.00059	CcSEcCtD
Cephalexin—Vomiting—Epirubicin—pancreatic cancer	0.000226	0.000573	CcSEcCtD
Cephalexin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000225	0.000571	CcSEcCtD
Cephalexin—Rash—Epirubicin—pancreatic cancer	0.000224	0.000568	CcSEcCtD
Cephalexin—Dermatitis—Epirubicin—pancreatic cancer	0.000223	0.000568	CcSEcCtD
Cephalexin—Headache—Epirubicin—pancreatic cancer	0.000222	0.000565	CcSEcCtD
Cephalexin—Dizziness—Doxorubicin—pancreatic cancer	0.000217	0.000551	CcSEcCtD
Cephalexin—Nausea—Epirubicin—pancreatic cancer	0.000211	0.000535	CcSEcCtD
Cephalexin—Vomiting—Doxorubicin—pancreatic cancer	0.000209	0.00053	CcSEcCtD
Cephalexin—Rash—Doxorubicin—pancreatic cancer	0.000207	0.000526	CcSEcCtD
Cephalexin—Dermatitis—Doxorubicin—pancreatic cancer	0.000207	0.000525	CcSEcCtD
Cephalexin—Headache—Doxorubicin—pancreatic cancer	0.000206	0.000522	CcSEcCtD
Cephalexin—Nausea—Doxorubicin—pancreatic cancer	0.000195	0.000495	CcSEcCtD
